Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregation |
| |
| Authors: | Parker Michael H Chen Robert Conway Kelly A Lee Daniel H S Luo Chi Boyd Robert E Nortey Samuel O Ross Tina M Scott Malcolm K Reitz Allen B |
| |
| Affiliation: | Drug Discovery Division, Johnson and Johnson Pharmaceutical Research and Development, Spring House, PA 19477, USA. |
| |
| Abstract: | A concise synthesis of the beta-amyloid(1-42 )aggregation inhibitor (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene [(-)-2] has been developed. The key step is a regio- and diastereoselective hydroboration-amination sequence to convert alkene into amine. Enantiomeric resolution was achieved by recrystallization of amine as the dibenzoyl-D-tartaric acid salt. Hydroquinone is a potent inhibitor of the fibrillar aggregation of beta-amyloid as determined in two different assay systems. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
